New Hot Flash Drug Hits NHS + The Menopause Marketing Explosion episode artwork

EPISODE · Apr 6, 2026 · 8 MIN

New Hot Flash Drug Hits NHS + The Menopause Marketing Explosion

from Hot Flasher

This episode covers the NHS approval of fezolinetant, a new non-hormone drug for hot flashes, the concerning surge in menopause product marketing, and breakthrough research on how menopause changes brain structure and function. Nykki discusses both the promise and pitfalls of the current menopause treatment landscape. Key Takeaways: • Fezolinetant, a new non-hormone drug that blocks neurokinin 3 receptors, is now available on NHS and can reduce hot flash frequency by about half • The menopause product market is projected to reach $24 billion by 2030, but many products lack rigorous clinical testing • New research from 800+ women shows menopause causes measurable changes in brain structure and connectivity, particularly in areas controlling memory and executive function • Women with more severe cognitive symptoms during menopause are also more likely to experience depression and anxiety • Some brain changes during menopause may be adaptive, with brains developing new pathways to maintain function Sources & References: • New non-hormone drug fezolinetant now available on NHS for hot flashes (The Guardian (https://news.google.com/rss/articles/CBMisgFBVV95cUxOZkpUb0pLOERmUkF0T0dnRjRZQll1bktCRGNfSVZSQmJDbUJBREl3cVdXQzh3eS1YTTJQUURyeVRNaDZlTF9ObGRTWHlFeFo1d1Bib2stOXpfcFJnb2JmWERwbV9CcE12U3JCM2d1ZFlCWW5fNDdaVlZrZnVsQ2JvUTZqemZqMXFuQ2dHdlQzdVBkUjZiYTVTQWpJVTcwOTV5RUljczZtMFByODlubjVnZmNR?oc=5)) • Doctors warn against menopause product marketing surge (AP News (https://news.google.com/rss/articles/CBMipAFBVV95cUxNQUxUSFZuVTJLNS0xcjNlTFVmVDRXV1dpSFExLXpWQlI2ZEM2ZW1xVHp3QVNSOTA5MzNiUTJmeFplQVU3aVhaaWVLSzh3N3k0Y1dpNHk3V1RaLWNETWI4QUttUlpvRHBmVUl5UzNzdEQtUTBJM3MzSlFNUFFQeURZV003bXppMnk4cjlHY3dXdHRKVGhiakNaWXBySnQ3dERmN1RIVA?oc=5)) • New research reveals how menopause affects brain, cognition, and mental health (The Conversation (https://news.google.com/rss/articles/CBMitwFBVV95cUxOdmVQdlJzc243YzBXMUZRc3k5eWZtM2ZsdW9wNUxIRjc0eXdnOWFwMHl6Vm9BMHZKNEFIYnBmSlU3S09ha0J0a3RjaWtvNDhQZ3hiNGxpcXJFc1lOZmgxRlRXd1g3MGZBbzhXLW1uMUZteFRYUXV5aERYVVBjWGVxMGczdkZMakY1VzU0eDlSX3hJV2Zxc2c2UTF5OGlpUnNUQ083NG1vQjFBNm4zeUF6el9hbmNidjA?oc=5)) Listen with full show notes: https://hotflasher.com/episodes/2026-04-06-research-roundup Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

Episode metadata supplied by the publisher feed · Published Apr 6, 2026

Embed this episode

A breakthrough hot flash drug arrives on NHS, plus why doctors are worried about the menopause product marketing surge and new brain research.

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

New Hot Flash Drug Hits NHS + The Menopause Marketing Explosion

0:00 8:05

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Hot Flasher?

This episode is 8 minutes long.

When was this Hot Flasher episode published?

This episode was published on April 6, 2026.

Can I download this Hot Flasher episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!